The theory put forward in this review anticipates potential difficulties with chronic administration of oxytocin in autism (after the signs and symptoms have become established) and calls for examining a more targeted (possibly neurodevelopmental) approach that reinforces the proper contextualization needed to assign saliency and promote appropriate models of the prosocial self. The gene discussed is OXT; the disease is autism.